A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction
Clinical trial NCT05139615 · TERMINATED
Trial details
- NCT number
- NCT05139615
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2022-09-19
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.